Gene · 60489
Papers3,812
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,812
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selection and characterization of aptamers targeting the Vif-CBFβ-ELOB-ELOC-CUL5 complex. | J Biochem | 2024 | 38740386 | PubTator, text mining | PubMed |
| The implications of APOBEC3-mediated C-to-U RNA editing for human disease. | Commun Biol | 2024 | 38704509 | PubTator, text mining | PubMed |
| Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction. | Viruses | 2024 | 38675833 | PubTator, text mining | PubMed |
| Protein Interaction Map of APOBEC3 Enzyme Family Reveals Deamination-Independent Role in Cellular Function. | Mol Cell Proteomics | 2024 | 38548018 | PubTator, text mining | PubMed |
| Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses. | Proc Natl Acad Sci U S A | 2024 | 38502701 | PubTator, text mining | PubMed |
| Unraveling the role of M1 macrophage and CXCL9 in predicting immune checkpoint inhibitor efficacy through multicohort analysis and single-cell RNA sequencing. | MedComm (2020) | 2024 | 38434763 | PubTator, text mining | PubMed |
| Construction of an immune-related prognostic signature and lncRNA-miRNA-mRNA ceRNA network in acute myeloid leukemia. | J Leukoc Biol | 2024 | 38393298 | PubTator, text mining | PubMed |
| Monitoring APOBEC3A protein levels in human cancer cells. | Methods Cell Biol | 2024 | 38359985 | PubTator, text mining | PubMed |
| Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes. | BMC Genomics | 2024 | 38308202 | PubTator, text mining | PubMed |
| Large overlap in neutrophil transcriptome between lupus and COVID-19 with limited lupus-specific gene expression. | Lupus Sci Med | 2024 | 38302132 | PubTator, text mining | PubMed |
| Expanded palette of RNA base editors for comprehensive RBP-RNA interactome studies. | Nat Commun | 2024 | 38287010 | PubTator, text mining | PubMed |
| CD4+ T cells with latent HIV-1 have reduced proliferative responses to T cell receptor stimulation. | J Exp Med | 2024 | 38270554 | PubTator, text mining | PubMed |
| Gene expression profiling of host lipid metabolism in SARS-CoV-2 infected patients: a systematic review and integrated bioinformatics analysis. | BMC Infect Dis | 2024 | 38263024 | PubTator, text mining | PubMed |
| APOBEC Mutagenesis in Cancer Development and Susceptibility. | Cancers (Basel) | 2024 | 38254863 | PubTator, text mining | PubMed |
| A computational exploration of global and temporal dynamics of selection pressure on HIV-1 Vif polymorphism. | Virus Res | 2024 | 38237808 | PubTator, text mining | PubMed |
| EPRIM: An approach of identifying cancer immune-related epigenetic regulators. | Mol Ther Nucleic Acids | 2024 | 38222302 | PubTator, text mining | PubMed |
| Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans. | EBioMedicine | 2024 | 38215691 | PubTator, text mining | PubMed |
| Murine leukemia virus infection of non-dividing dendritic cells is dependent on nucleoporins. | PLoS Pathog | 2024 | 38215165 | PubTator, text mining | PubMed |
| Effectiveness and safety of azvudine in older adults with mild and moderate COVID-19: a retrospective observational study. | BMC Infect Dis | 2024 | 38177982 | PubTator, text mining | PubMed |
| Critical contribution of mitochondria in the development of cardiomyopathy linked to desmin mutation. | Stem Cell Res Ther | 2024 | 38167524 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60489/papers?page=6